Elevated transforming growth factor β1 in plasma of primary open-angle glaucoma patients

Invest Ophthalmol Vis Sci. 2014 Jul 24;55(8):5291-7. doi: 10.1167/iovs.14-14578.

Abstract

Purpose: To test the hypothesis that primary open-angle glaucoma (POAG) patients have a systemic elevation of transforming growth factor β1 (TGFβ1).

Methods: Plasma was prepared from blood samples drawn from patients of the Vanderbilt Eye Institute during clinic visits. Concentrations of total TGFβ1 and thrombospondin-1 (TSP1) in plasma were determined by ELISA. Statistical significance of differences between POAG and control samples was evaluated by Mann-Whitney test. Regression analysis was used to evaluate correlations between plasma TGFβ1 and patient age and between plasma TGFβ1 and TSP1.

Results: Plasma samples were obtained from 148 POAG patients and 150 controls. Concentration of total TGFβ1 in the plasma of POAG patients (median = 3.25 ng/mL) was significantly higher (P < 0.0001) than in controls (median = 2.46 ng/mL). Plasma TGFβ1 was not correlated with age of patient (P = 0.17). Thrombospondin-1 concentration was also significantly higher (P < 0.0001) in POAG patients (median = 0.774 μg/mL) as compared to controls (median = 0.567 μg/mL). Plasma total TGFβ1 and TSP1 concentrations were linearly correlated (P < 0.0001).

Conclusions: Plasma samples from POAG patients display elevated total TGFβ1 compared to controls, consistent with elevated systemic TGFβ1 in POAG patients.

Keywords: aqueous humor; glaucoma; plasma; platelet; transforming growth factor beta.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Case-Control Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Glaucoma, Open-Angle / blood*
  • Humans
  • Male
  • Middle Aged
  • Regression Analysis
  • Thrombospondin 1 / blood
  • Transforming Growth Factor beta1 / blood*

Substances

  • Thrombospondin 1
  • Transforming Growth Factor beta1